Consumo de azitromicina, claritromicina y eritromicina en un establecimiento farmacéutico en el distrito de La Esperanza en el periodo de enero – diciembre del 2021
No Thumbnail Available
Date
2022
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Nacional de Trujillo
Abstract
En el presente informe se tuvo como objetivo determinar el consumo de azitromicina, claritromicina y eritromicina en un establecimiento del distrito de La Esperanza en el periodo enero – diciembre del 2021 a fin de contribuir al uso racional de los medicamentos. Los datos de las unidades vendidas de Azitromicina, Claritromicina, Eritromicina se extrajeron del sistema de ventas del establecimiento Farmasoft 2020, solo teniendo en cuenta los meses de estudio de enero – diciembre de 2021. La metodología que se empleó fue a través del número de dosis diaria definida/ 1000 habitantes/día (DHD). Se obtuvo como resultado que el macrólido con mayor consumo mensual fue Azitromicina con un total de 1078 unidades dispensadas, teniendo una mayor demanda en el mes de Abril. El segundo macrólido más consumido fue Azonacaf con un total de 683 unidades dispensadas, seguido por Trimax con un total de 598 unidades dispensadas, seguido por Claritromicina con un total de 548 unidades dispensadas, seguido por Eritromicina con un total de 126 unidades dispensadas. Se calculó el consumo mensual de estos medicamentos empleando en método de dosis diaria definida/ 1000 habitantes/día, hallándose un valor mayor en Azitromicina con un valor de 5.11.
ABSTRACT This report aimed to determine the consumption of Azithromycin, Clarithromycin, Erythromycin in an establishment in the district of La Esperanza in the period January – December 2021 in order to contribute to the rational use of medicines. The data of the units sold of Azithromycin, Clarithromycin, Erythromycin were extracted from the sales system of the Farmasoft 2020 establishment, only taking into account the study months of January – December 2021. The methodology used was through the number of defined daily dose / 1000 inhabitants / day (DHD). As a result, the macrolide with the highest monthly consumption was Azithromycin with a total of 1078 units dispensed, having a higher demand in the month of April. The second most consumed macrolide was Azonacaf with a total of 683 units dispensed, followed by Trimax with a total of 598 units dispensed, followed by Clarithromycin with a total of 548 units dispensed, followed by Erythromycin with a total of 126 units dispensed. The monthly consumption of these medications was calculated using the defined daily dose method/1000 inhabitants/day, finding a higher value in Azithromycin with a value of 5.11.
ABSTRACT This report aimed to determine the consumption of Azithromycin, Clarithromycin, Erythromycin in an establishment in the district of La Esperanza in the period January – December 2021 in order to contribute to the rational use of medicines. The data of the units sold of Azithromycin, Clarithromycin, Erythromycin were extracted from the sales system of the Farmasoft 2020 establishment, only taking into account the study months of January – December 2021. The methodology used was through the number of defined daily dose / 1000 inhabitants / day (DHD). As a result, the macrolide with the highest monthly consumption was Azithromycin with a total of 1078 units dispensed, having a higher demand in the month of April. The second most consumed macrolide was Azonacaf with a total of 683 units dispensed, followed by Trimax with a total of 598 units dispensed, followed by Clarithromycin with a total of 548 units dispensed, followed by Erythromycin with a total of 126 units dispensed. The monthly consumption of these medications was calculated using the defined daily dose method/1000 inhabitants/day, finding a higher value in Azithromycin with a value of 5.11.
Description
Keywords
Azitromicina, Claritromicina, Eritromicina, Consumo, Establecimiento farmacéutico, DDD, Macrólido